Analyst Consensus
- Current Price
- 400.96 $
- Target (Low)
- 287.00 $
- Target (Mean)
- 409.77 $
- Target (High)
- 492.00 $
- Recommendation
- Buy
- Number of Analysts
- 26
Recommendation Distribution
Recommendation Distribution| Strong Buy | 6 |
|---|
| Buy | 17 |
|---|
| Hold | 4 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 2.7%
- Operating Margin
- 8.0%
- Gross Margin
- 18.8%
- Return on Equity (ROE)
- 12.2%
- Return on Assets (ROA)
- 3.8%
- Revenue Growth
- 2.0%
- Earnings Growth
- 0.7%
- Debt/Equity
- 73.98
- Current Ratio
- 0.80
- Beta
- 0.65
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 17, 2026 | Leerink Partners | Outperform → Outperform |
| Jun 8, 2026 | Mizuho | Outperform → Outperform |
| Jun 8, 2026 | JP Morgan | Overweight → Overweight |
| Jun 4, 2026 | Morgan Stanley | Overweight → Overweight |
| Jun 4, 2026 | B of A Securities | Neutral → Buy |
| Jun 1, 2026 | Truist Securities | Buy → Buy |